Steward Partners Investment Advisory, LLC Cellectis S.A. Transaction History

Steward Partners Investment Advisory, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 08, 2022	SELL	$8.01 - $12.84 $801 - $1,284	-100 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$18.19 - $33.25 $3,638 - $6,650	-200 Reduced 66.67%	100 $2,000
Q4 2020 Feb 11, 2021	BUY	$15.87 - $31.64 $1,587 - $3,164	100 Added 50.0%	300 $8,000
Q3 2020 Oct 30, 2020	SELL	$15.7 - $20.84 $1,570 - $2,084	-100 Reduced 33.33%	200 $4,000
Q2 2020 Aug 06, 2020	BUY	$8.21 - $21.02 $2,463 - $6,306	300 New	300 $5,000

9.73M

30.9K

Ticker CLLS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,510,800
Market Cap $101M
Description
Cellectis S.A., a clinical stage biotechnological company, develops immuno-oncology products based on gene-edited T-cells that express chimeric antigen receptors to target and eradicate cancer cells. It operates through two segments, Therapeutics and Plants. The company is developing UCART19, an allogeneic T-cell product candidate for the treatm...

Get notified when there are updates to the investment portfolio of Steward Partners Investment Advisory, LLC, based on Form 13F filings with the SEC.

Stay updated on Steward Partners Investment Advisory, LLC with notifications on news.